DK0417473T3 - Fremgangsmåde til behandling af cardial samt vaskulær hypertrofi og hyperplasi - Google Patents

Fremgangsmåde til behandling af cardial samt vaskulær hypertrofi og hyperplasi

Info

Publication number
DK0417473T3
DK0417473T3 DK90115230.6T DK90115230T DK0417473T3 DK 0417473 T3 DK0417473 T3 DK 0417473T3 DK 90115230 T DK90115230 T DK 90115230T DK 0417473 T3 DK0417473 T3 DK 0417473T3
Authority
DK
Denmark
Prior art keywords
treatment
hyperplasia
cardiac
administration
well
Prior art date
Application number
DK90115230.6T
Other languages
Danish (da)
English (en)
Inventor
Wolfgang Dr Linz
Wolfgang Dr Scholz
Hansjoerg Dr Urbach
Bernward Prof Dr Schoelkens
Gabriele Dr Wiemer
Rainer Dr Henning
Volker Dr Teetz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6386970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0417473(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0417473T3 publication Critical patent/DK0417473T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crucibles And Fluidized-Bed Furnaces (AREA)
  • Preliminary Treatment Of Fibers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Element Separation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK90115230.6T 1989-08-11 1990-08-08 Fremgangsmåde til behandling af cardial samt vaskulær hypertrofi og hyperplasi DK0417473T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3926606A DE3926606A1 (de) 1989-08-11 1989-08-11 Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie

Publications (1)

Publication Number Publication Date
DK0417473T3 true DK0417473T3 (da) 1993-12-13

Family

ID=6386970

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90115230.6T DK0417473T3 (da) 1989-08-11 1990-08-08 Fremgangsmåde til behandling af cardial samt vaskulær hypertrofi og hyperplasi

Country Status (22)

Country Link
US (1) US5231083A (ja)
EP (1) EP0417473B1 (ja)
JP (1) JP3452199B2 (ja)
KR (1) KR0185969B1 (ja)
AT (1) ATE94409T1 (ja)
AU (1) AU631914B2 (ja)
CA (1) CA2023089C (ja)
CS (1) CS277644B6 (ja)
DD (1) DD297063A5 (ja)
DE (2) DE3926606A1 (ja)
DK (1) DK0417473T3 (ja)
ES (1) ES2059931T3 (ja)
FI (1) FI903936A0 (ja)
HU (1) HU205008B (ja)
IE (1) IE64604B1 (ja)
IL (1) IL95327A (ja)
NO (1) NO306979B1 (ja)
NZ (1) NZ234836A (ja)
PH (1) PH30831A (ja)
PL (1) PL286442A1 (ja)
PT (1) PT94957B (ja)
ZA (1) ZA906327B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE157871T1 (de) 1994-05-19 1997-09-15 Mitsubishi Chem Corp Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind
SG68529A1 (en) * 1995-05-25 1999-11-16 Univ Singapore The use of des-aspartate-angiotensin i (agr-val-tyr-ile-his-pro-phe-his-leu) as an anti-cardiac hypertrophic agent
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
WO2001015674A2 (en) * 1999-08-30 2001-03-08 Aventis Pharma Deutschland Gmbh Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
US6395767B2 (en) * 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
EP1817007A2 (en) * 2004-11-05 2007-08-15 King Pharmaceuticals Research and Development Inc. Stabilized individually coated ramipril particles, compositions and methods
US8980924B2 (en) 2010-11-24 2015-03-17 The Trustees Of Columbia University In The City Of New York Non-retinoid RBP4 antagonist for treatment of age-related macular degeneration and stargardt disease
US9333202B2 (en) 2012-05-01 2016-05-10 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
US10273243B2 (en) 2013-03-14 2019-04-30 The Trustees Of Columbia University In The City Of New York 4-phenylpiperidines, their preparation and use
US9944644B2 (en) 2013-03-14 2018-04-17 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles their preparation and use
ES2700541T3 (es) 2013-03-14 2019-02-18 Univ Columbia Octahidrociclopentapirroles, su preparación y uso
US9938291B2 (en) 2013-03-14 2018-04-10 The Trustess Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
WO2015168286A1 (en) 2014-04-30 2015-11-05 The Trustees Of Columbia University In The City Of New York Substituted 4-phenylpiperidines, their preparaiton and use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4311705A (en) * 1980-10-06 1982-01-19 E. R. Squibb & Sons, Inc. Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines
US4337201A (en) * 1980-12-04 1982-06-29 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl substituted prolines
US4381297A (en) * 1981-05-04 1983-04-26 E. R. Squibb & Sons, Inc. Substituted carbonyl phosphinyl-alkanoyl compounds
US4602002A (en) * 1983-02-07 1986-07-22 Merck & Co., Inc. N-carboxymethyl substituted lysyl and α-(ε-aminoalkyl) glycyl amino acid antihypertensive agents
US4548941A (en) * 1984-07-30 1985-10-22 Merck & Co., Inc. 1,5-Methano-1H-4-benzazonine dicarboxylates, process for preparing and use as calcium blockers
US4587253A (en) * 1984-07-30 1986-05-06 Merck & Co., Inc. Bridged pyridine compounds useful as calcium channel blockers and analgesics
US4599341A (en) * 1984-10-01 1986-07-08 Merck & Co., Inc. Substituted and bridged pyridines useful as calcium channel blockers
US4656188A (en) * 1985-10-09 1987-04-07 Merck & Co., Inc. Ace inhibitors in macular degeneration
DE3705220A1 (de) * 1987-02-19 1988-09-01 Boehringer Ingelheim Kg Mittel zur behandlung von coronarerkrankungen oder organischem hirnsyndrom
ZA896851B (en) * 1988-09-14 1990-06-27 Hoffmann La Roche Use of ace-inhibitors

Also Published As

Publication number Publication date
PT94957A (pt) 1991-05-22
HUT54504A (en) 1991-03-28
IL95327A0 (en) 1991-06-30
NZ234836A (en) 1997-05-26
HU205008B (en) 1992-03-30
PL286442A1 (en) 1992-03-09
DD297063A5 (de) 1992-01-02
ES2059931T3 (es) 1994-11-16
HU904966D0 (en) 1991-01-28
NO903532L (no) 1991-02-12
PH30831A (en) 1997-10-17
CA2023089C (en) 2003-01-14
KR0185969B1 (ko) 1999-05-01
ATE94409T1 (de) 1993-10-15
AU6092090A (en) 1991-02-14
CS277644B6 (en) 1993-03-17
DE3926606A1 (de) 1991-02-14
CS395890A3 (en) 1992-08-12
DE59002721D1 (de) 1993-10-21
US5231083A (en) 1993-07-27
PT94957B (pt) 1997-05-28
EP0417473B1 (de) 1993-09-15
NO306979B1 (no) 2000-01-24
NO903532D0 (no) 1990-08-10
IL95327A (en) 1995-10-31
KR910004189A (ko) 1991-03-28
ZA906327B (en) 1991-05-29
EP0417473A1 (de) 1991-03-20
IE64604B1 (en) 1995-08-23
CA2023089A1 (en) 1991-02-12
AU631914B2 (en) 1992-12-10
IE902910A1 (en) 1991-02-27
FI903936A0 (fi) 1990-08-09
JPH0383957A (ja) 1991-04-09
JP3452199B2 (ja) 2003-09-29

Similar Documents

Publication Publication Date Title
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
DK0417473T3 (da) Fremgangsmåde til behandling af cardial samt vaskulær hypertrofi og hyperplasi
DK104292A (da) Heterocycliske forbindelser og fremgangsmaade til deres fremstilling
DK490486D0 (da) Sammensaetning til behandling af atherosclerose, tromboser og/eller perifere karsygdomme
FI840463A0 (fi) Vissa bensazokinon- och bensazoninonderivat
DK495683A (da) Beta-carboliner, fremgangsmaade til fremstilling af samme og farmaceutisk praeparat indeholdende samme
NO165921C (no) Fremgangsmaate for fremstilling av disubstituerte prolinderivater.
NO952205L (no) Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
DK165247C (da) 2,3,4,5-substituerede 1,6-naphthyridinderivater, deres fremstilling samt anvendelse af disse til fremstilling af laegemidler til bekaempelse af cardiale, cerebrale og perifere karlidelser, myocardial iskaemi, cerebral infarkt, lungethrombose, stenoser, arterioscleroser og hjerte-kredsloebslidelser og laegemiddel indeholdende disse derivater
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
DK0736009T3 (da) N-oxider af 4-arylpiperaziner og 4-arylpiperidiner som antipsykotiske medikamenter
DE69106386T2 (de) Oxysulfonylcarbamate.
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
ES2147316T3 (es) 1-cicloalqueniltetrazolinonas.
CO4770971A1 (es) Compuestos quimicos
FI944967A (fi) Menetelmiä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten ja niiden välituotteiden valmistamiseksi
DK572189A (da) Substituerede adeninderivater og farmaceutisk praeparat indeholdende dem